Illumina, Inc.
NEWS
Arbor Biotechnologies came out of stealth mode yesterday with a $15.6 million Series A financing round.
The new campus will consolidate some 400 employees in one place and give more space to the startup companies it helps.
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference.
It was a pretty good year for the stock market, but how about for biotech stocks?
It’s not always easy to see when a company is a “disruptor,” which is to say, that it causes a paradigm shift in how an industry operates.
Future generations might look back and wish their parents and grandparents had added these three top stocks to their portfolios today.
The new venture capital fund with a focus on early-stage companies is making waves in the biotech world.
JOBS
IN THE PRESS